2019
DOI: 10.1101/594655
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Modern clinical Mycobacterium tuberculosis strains leverage type I IFN pathway for a pro-inflammatory response in the host

Abstract: 12Host phagocytes respond to infections by innate defense mechanisms through metabolic 13 shuffling in order to restrict the invading pathogen. However, this very plasticity of the host 14 provides an ideal platform for pathogen mediated manipulation. By employing the macrophage 15 model of Mtb infection, we identify an important strategy employed by modern clinical lineages 16 in regulating the host immune-metabolism axis. The potent ability of these strains to specifically 17 elicit a strong and early macrop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
5
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
3
1

Relationship

2
2

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 53 publications
(51 reference statements)
2
5
0
Order By: Relevance
“…The precise contributions of lysosomal rewiring to Mtb trafficking and survival during in vivo infections require further studies. Similarly, it will be interesting to extend these studies to clinical isolates of Mtb, which differ in SL-1 gene expression and lipid levels (82)(83)(84). Some strains of the "ancestral" Clade 2 show reduced expression of genes in the SL-1 biosynthetic pathway (85), whereas a recent report shows an Mtb strain belonging to the ancestral lineage with a point mutation in the papA2 gene, which confers it a loss of SL-1 phenotype (86).…”
Section: Discussionmentioning
confidence: 99%
“…The precise contributions of lysosomal rewiring to Mtb trafficking and survival during in vivo infections require further studies. Similarly, it will be interesting to extend these studies to clinical isolates of Mtb, which differ in SL-1 gene expression and lipid levels (82)(83)(84). Some strains of the "ancestral" Clade 2 show reduced expression of genes in the SL-1 biosynthetic pathway (85), whereas a recent report shows an Mtb strain belonging to the ancestral lineage with a point mutation in the papA2 gene, which confers it a loss of SL-1 phenotype (86).…”
Section: Discussionmentioning
confidence: 99%
“…The effect of the combination was again better in controlling bacterial numbers in spleens of treated mice wherein HR did not reduce CFU in contrast to the 6-8-fold lower bacterial numbers with the combination. We and several other groups have identified type I IFN as an early response of host macrophages to infection with Mtb strains (41,42,49,66). With recent evidences implicating type I IFN as a pathogen beneficial response, we hypothesized that attenuating this axis would prove beneficial in controlling bacteria in macrophages.…”
Section: Resultsmentioning
confidence: 96%
“…Macrophages respond to Mtb infection by elaborating an array of signaling cascades and effector functions with the nucleic acid driven type I IFN response as an active and dominant response to during infection (42,(44)(45)(46)(47)(48)(49). We questioned the benefit to Mtb in actively stimulating this response and hypothesized that suppressing this response in cells would alter macrophage infection dynamics.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Despite these differences, our data shows that altered lysosomal homeostasis, mediated in part by SL-1, is central to both human and mouse infection models. Clinical isolates of Mtb exhibit clade specific virulence patterns with strong correlations of their phylogenetic relationships with gene expression profiles and host inflammatory responses (Portevin et al, 2011; Reiling et al, 2013; Shankaran et al, 2019). Some strains of the ‘ancestral’ Clade 2 show reduced expression of genes in the SL-1 biosynthetic pathway (Homolka et al, 2010), while a recent report shows an Mtb strain belonging to the ancestral lineage L1 having a point mutation in the pap A2 gene, which confers it a loss of SL-1 phenotype (Panchal et al, 2019).…”
Section: Discussionmentioning
confidence: 99%